Oncotarget: A top Peer-reviewed Journal

From the moment it was founded in 2010, Oncotarget has crafted a good name for itself as one of the prominent peer-reviewed journals internationally. On top of that, Oncotarget has been given the highest ranking by the Scopus/SJR for its exceptional support in medicine and oncology sector. This increase in popularity forced the medical journal to make a decision of expanding their territory to be covered by the articles to be encompassed in its publications.

The field has extended from oncology to other niches comprising the cell biology, neuroscience, cardiology, and pharmacology. The journal approves papers that cover the metabolism and endocrinology among other fields.

Journal Profile: Success Factors

Oncotarget is one of the weekly publications that is prepared by the Impact Journals in English. This medicine publication is peer-reviewed by highly skilled editorial board members and professional editors. Oncotarget works with more than hundred editorial board members and editors. All of them are specialized in a broad range of fields comprising:

  • Pathology
  • Oncology
  • Aging
  • Immunology
  • Microbiology
  • Cell biology

Some of the professionals such as Andrew Schally are brilliant research scientist who has won prestigious Nobel Prize. The exceptional service delivery that was made efficient by the journal’s editorial board members was acknowledged in 2013 when four editors were awarded the breakthrough prizes. These people are trying to bring their knowledge and skills to Oncotarget. It is evident that they have played a vital role in helping the journal build a name for itself. Other individuals such as Mikhail Blagosklonny and Andrei V. Gudkov who are known as the founding editors in chief are knowledgeable research scientist who has participated in research for numerous years.

Just like open access, Oncotarget tries to approve all the articles from authors around the globe. This serves as a clear indication of its determination towards knowledge and information dissemination with the view of attaining the ultimate objective. Note that the mission of this journal is to make sure that the world is free from disease. It has an open-access rule that has played a vital role in driving its popularity within the scientific communities.